- Profile
- prev
- next
General
-
Headquarters
Miami, Florida 33136, United States
-
Founders & Team
Robert L. Buchanan
-
Year Founded
2019
-
Number of employees
10
-
Company type
Private company
-
Total funding ($M)
5.5
Technical Details
-
Aging Target
Altered intercellular communication
About
Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. We are a platform company that can deliver the adhesion molecule E-selectin using different cell and synthetic vector technologies. We work on rare vascular diseases as well as more common indications effecting large patient populations.